BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics and beta-blocking effects of timolol in poor and extensive metabolizers of debrisoquin. 1985

J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward

We studied the pharmacokinetics and beta-blocking effects of a single, oral 20 mg dose of timolol in six poor metabolizers (PMs) and six extensive metabolizers (EMs) of debrisoquin. The plasma timolol concentration was significantly higher in PMs than in EMs. There was a fourfold difference in mean AUC (1590 +/- 1133 vs. 394 +/- 239 ng X hr/ml; P less than 0.01) and a twofold difference in mean t1/2 (7.5 +/- 3 vs. 3.7 +/- 1.7 hours; P less than 0.01), reflecting differences in oral clearance (13.1 +/- 7.8 vs. 48.5 +/- 23.2 L/hr; P less than 0.01). The degree of beta-blockade was greater in PMs than in EMs at 12 hours (30.9% vs. 18.2%; P less than 0.05) and at 24 hours (28.3% vs. 13.1%; P less than 0.05). In the group as a whole the metabolic ratio correlated positively with both kinetic data and beta-blockade, but some overlap was observed. Hence timolol metabolism appears to be subject to debrisoquin-type polymorphism, which results in interphenotypic variation in plasma concentration and beta-blocking effect.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003647 Debrisoquin An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. Debrisoquine,Tendor
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
Metabolism of methoxyphenamine in extensive and poor metabolizers of debrisoquin.
August 1985, Clinical pharmacology and therapeutics,
J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers.
December 1983, Clinical pharmacology and therapeutics,
J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
Pharmacokinetics and beta-blocking effects of transdermal timolol.
January 1993, European journal of clinical pharmacology,
J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
Systemic absorption of ocular timolol in poor and extensive metabolizers of debrisoquine.
January 1991, Journal of ocular pharmacology,
J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers.
July 2006, European journal of clinical pharmacology,
J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers.
June 2000, Journal of clinical psychopharmacology,
J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
The effects of timolol on intraocular pressure and exercise heart rate in poor and extensive debrisoquine metabolizers.
January 1990, International journal of clinical pharmacology research,
J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects.
January 1996, European journal of clinical pharmacology,
J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers.
July 2006, Journal of clinical pharmacology,
J C McGourty, and J H Silas, and J J Fleming, and A McBurney, and J W Ward
Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment.
April 1987, Pharmacology & toxicology,
Copied contents to your clipboard!